Mrs. Grichuhin credits much of her success to the mentorship she received throughout her career, which was invaluable in developing her understanding of the clinical field.
WESTMINSTER, MD, April 15, 2022 /24-7PressRelease/ -- Kendra Grichuhin has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Mrs. Grichuhin earned an Associate of Science from the Community College of Baltimore County and went on to attain a Bachelor of Science from Towson University. She subsequently earned a Master of Science in microbiology from the University of Iowa in 2006. Following this accomplishment, she began her career working with genotyping samples for Vanda Pharmaceuticals for two years until joining the regulatory affairs department in 2008. In 2015, Mrs. Grichuhin earned a promotion to a regulatory and quality assurance manager. In 2016, Mrs. Grichuhin started working at Supernus Pharmaceuticals as an Assistant Director of Regulatory Affairs. Since 2021, Mrs. Grichuhin has served as the director of regulatory affairs for Supernus Pharmaceuticals Inc. As part of her dedication to her field, she is a member of the Regulatory Affairs Professionals Society.
During her time at Supernus Pharmaceuticals, she served as the regulatory lead for the program for Oxtellar XR, an epilepsy medication, as well as the regulatory representative for one of their investigational programs. Additionally, she became the regulatory and program lead for their company regarding the development of a drug with a novel mechanism of action for treating depression, as well as a nonstimulant medication for treating ADHD. An expert in Food and Drug Administration (FDA) communications, submissions and strategy, Mrs. Grichuhin develops strategies for the clinical development program to be compliant with the FDA.
Mrs. Grichuhin credits much of her success to the mentorship she received throughout her career, which was invaluable in developing her understanding of the clinical field. Originally studying to become a nurse, she cultivated a specific passion for microbiology specifically and resolved to pursue her education accordingly. The pharmaceutical industry interested her because of its continual developments and innovations. Looking toward the future, she plans to grow in her position, with the eventual goal of rising to a higher executive level. Ms. Grichuhin also hopes to gain additional approvals for products on the market to help patients.
About Marquis Who's Who®
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® now publishes many Who's Who titles, including Who's Who in America®, Who's Who in the World®, Who's Who in American Law®, Who's Who in Medicine and Healthcare®, Who's Who in Science and Engineering®, and Who's Who in Asia®. Marquis® publications may be visited at the official Marquis Who's Who® website at www.marquiswhoswho.com.
# # #